Treatment of cancer involving mutated KRAS or BRAF genes

Details for Australian Patent Application No. 2010314798 (hide)

Owner Cephalon Australia Pty Ltd

Inventors Kienzle, Norbert Alexander; Doyle, Anthony Gerard; Rowe, Tony

Agent Davies Collison Cave

Pub. Number AU-A-2010314798

PCT Pub. Number WO2011/054030

Priority 61/258,518 05.11.09 US; 2010904107 13.09.10 AU

Filing date 29 October 2010

Wipo publication date 12 May 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/054030 Priority application(s): WO2011/054030

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010314799-Connector, and methods of use

2010314797-Method and system for providing maintenance verification